Question Bank › Growing out of the old self

Growing out of the old self

Growing out of the old self: management itself says the company has quietly become a different business, and the numbers

Calls Tested
492
Answered YES
4
Hit Rate
0.8%
rare by design

Harrow Health, Inc. (HROW) — this company's answers

NO on the Q4 2021 call 2022-03-10 C
The model's full reasoning — Q4 2021 call → NOWe need answer only YES or NO. Need analyze transcript. Need determine if management conveys both halves. Let's examine transcript. Harrow Health Q4 2021. CEO Mark Baum. Need see if management describes company as crossed into different kind of business, change already real, and reported results/perception lag change. Key excerpts: "our actions in 2021 were intensely focused on positioning Harrow Health to fulfill its vision of becoming a leading U.S. eye care company. For us, to execute on that vision, we are: one, focusing on ophthalmic surgical, chronic and acute care prescription pharmaceuticals; two, serving institutional customers... three, continuing to add high-value FDA-approved products to our portfolio." "In 2022, we are focused on building the infrastructure to support the significant growth that we anticipate over the next few years, beginning this year, not only from recent acquisitions of drug candidates like AMP-100 and MAQ-100, if they're approved by the FDA, but also from internally developed formulations that we expect to launch commercially over the next 18 months or so." "Also, we continue to be on the hunt for additional M&A opportunities... In order to support this growth, we are expanding our existing commercial infrastructure... We expect our team to be further expanded during 2022 as we prepare for the approval and launch of AMP-100 and the relaunch of IOPIDINE, MAXITROL and MOXEZA..." "We are also in the process of establishing our own internal analytical lab..." "This year is already shaping up to be a breakout year for Harrow. We continue to see strong daily revenues to this day. As we previously announced, October 16 of this year is our PDUFA date for AMP-100. And if approved, we intend to be ready a few months thereafter to launch AMP-100 into a market in which we have commercial credibility. That would be the U.S. ophthalmic surgical or procedure market. In addition, we expect to see value creation events from our noncontrolling equity positions in companies that were originally founded as Harrow Health subsidiaries before being deconsolidated." Then Q&A. Brooks asks about COVID. Mark says not material. Brooks: "You seem to be fairly optimistic... about FDA response on AMP-100... ability to get through FDA?" Mark: product patented, market, existing presence.

← Back to the full HROW analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management convey that THE COMPANY TODAY IS RUNNING ON A DIFFERENT BASIS THAN THE COMPANY ITS REPORTED RESULTS AND REPUTATION WERE BUILT ON \u2014 that is, does management itself describe the company as having crossed, recently and substantially, into being a different kind of business than it was, while making clear that this change is not yet what the reported numbers or the outside picture of the company reflect? Answer YES when management's own words convey, in whatever form fits the business, ONE coherent posture with BOTH halves present as a present-tense reality: (1) A CHANGE OF BASIS, ALREADY REAL. Management describes the company as now operating on a foundation that is genuinely different from what it used to run on \u2014 in whatever form fits the industry: what it sells, who pays it, how it earns, what it owns, what it can do, or what drives its results has changed at the root, and management treats this as an accomplished condition of the company today, grounded in things already happening or already in place (real current activity, completed work, business already being won or delivered), not as a plan, a launch announcement, or a vision. The change may have built over several periods or arrived recently; what matters is that management speaks about the new basis as how the company actually works NOW, not as where it is headed. (2) MANAGEMENT SAYS THE RECORD AND THE PERCEPTION LAG THE CHANGE. Management conveys \u2014 directly or plainly in substance \u2014 that the results being reported, or the way outsiders still see and measure the company, belong to the OLD basis: the new basis contributes only early or partially to the numbers just presented; the metrics, mix, or storyline people associate with the company describe what it was; or management indicates that what the company has already become will only become visible in results from here. The essence is a management team telling investors, in its own voice: the company you are grading is not quite the company we are now running. Answer NO if the call is ordinary reporting of a company continuing in its established form, however strong or confident. NO if the change described is a routine product refresh, a normal line extension, ordinary mix improvement, or incremental progress within the same basis. NO if the new basis is only planned, being tested, launching soon, or described as a future direction rather than as already how the company operates. NO if management describes the change but conveys no sense that the reported results or outside perception lag it \u2014 for example if the new basis is already fully reflected in the numbers and fully understood. NO if the only contrast is between a bad quarter and a good quarter, or between this year and last year, within an unchanged business. NO if the framing is generic transformation, journey, or evolution boilerplate without a concrete description of what is different about how the company now works. NO if the idea appears only in an analyst's question or characterization that management does not itself affirm. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
SANG Sangoma Technologies Corporation Q2 2024 2024-02-08 D
WD Walker & Dunlop, Inc. Q2 2022 2022-08-09 C+
KD Kyndryl Holdings, Inc. Q4 2021 2022-03-01 C+
CAG Conagra Brands, Inc. Q2 2017 2016-12-22 C+

How the model reasoned

CALX · Q1 2023 → YESThe question is whether management conveys that the company today is running on a different basis than what its reported results and reputation were built on. Both parts: a change of basis already rea...YES The transcript shows management describing the company as now operating on a fundamentally different basis—selling into a new market of broadband service providers building consolidated networks, shifting from a legacy cyclical model to sequential revenue through platforms, clouds, and managed services—while treating this as an accomplished reality today, not a future plan. They emphasize numbers like 988 BSP deployments, 865 cloud customers, and 334 managed services customers, along with three years of over 25% growth, as evidence of this new foundation already in place.
SANG · Q2 2024 → YESThe question is whether management conveys that the company today is running on a different basis than the one its reported results and reputation were built on. Both parts: a real change of basis alr...
WD · Q2 2022 → YESThe question is whether management conveys that the company today is running on a different basis than the company its reported results and reputation were built on. Specifically, two parts: a change ...

More from the question bank

Their own money on the lineQuestions aim low, answers land highMid-period crossingsFree option on their own operationsThe company is outgrowing its own explanatioUndersized for what it has already been handAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.